Latest News about TEVA
Recent news which mentions TEVA
   Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
   
  
  
  October 03, 2024
  From Benzinga
 
   Teva Launches Generic Version Of Sandostatin In The US
   
  
  
  October 01, 2024
  From Benzinga
 
   $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
   
  
  
  September 30, 2024
  From Benzinga
 
   Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
   
  
  
  September 30, 2024
  From Benzinga
 
   If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today
   
  
  
  September 16, 2024
  From Benzinga
 From Benzinga
 
   Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
   
  
  
  September 10, 2024
  From Benzinga
 
   JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
   
  
  
  September 06, 2024
  From Benzinga
 
   Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
   
  
  
  September 06, 2024
  From Benzinga
 
   Key Takeaways From Teva Pharmaceutical Indus Analyst Ratings
   
  September 03, 2024
  Tickers 
   TEVA
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
   
  
  
  August 13, 2024
  From Benzinga
 
   The 7 Best Under $20 Stocks to Buy in August 2024
   
  
  
  August 07, 2024
  From InvestorPlace
 
   What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
   
  
  
  August 02, 2024
  From InvestorPlace
 From Benzinga
 From Benzinga
 Tickers 
   TEVA
  
  
  From Motley Fool
 From Benzinga
 From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  July 30, 2024
  From Benzinga
 From Benzinga
 
   Why Hims & Hers Heath Shares Are Surging Today
   
  
  
  July 22, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
   
  
  
  July 17, 2024
  From Benzinga
 
   3 No-Brainer Stocks to Buy With $200 Right Now
   
  
  
  July 17, 2024
  From Motley Fool
 
   Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
   
  
  
  July 16, 2024
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
